ProQR Therapeutics BV (PRQR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.59
• Market Cap: $162.23M
• EPS: $-0.48
• 52-Week High: $3.10
• 52-Week Low: $1.07

Market Sentiment

ProQR Therapeutics BV currently has a Neutral sentiment score of 0.12.

About ProQR Therapeutics BV

ProQR Therapeutics BV, headquartered in Leiden, the Netherlands, is a pioneering biopharmaceutical firm specializing in RNA-based therapies for severe genetic disorders. The company boasts a robust pipeline, featuring advanced candidates targeting both rare and prevalent diseases, and utilizes its proprietary technology platform to develop innovative solutions that tackle the root causes of these conditions. With a strong commitment to cutting-edge research and development, ProQR is positione...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for ProQR Therapeutics BV and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PRQR pay dividends?

ProQR Therapeutics BV (PRQR) does not currently pay a regular dividend.

What is PRQR's market cap?

ProQR Therapeutics BV (PRQR) has a market capitalization of $162.23M with a current stock price of $1.59.